Python-derived pTOS shows promise as a side-effect-free appetite suppressant, offering a new path for weight loss and metabolic therapies.

Facing growing numbers of would-be converts, Latin American Jewish communities are worried about being overwhelmed by mass conversions and having to filter out those whose motivations are not genuine.

Under the new priority voucher program (CNPV), the FDA has approved a new oral GLP-1 drug, Foundayo, offering an alternative ...

Can a heavyweight fighter eat whatever they want? Nutrition experts explain the science behind fuelling the likes of Fury and ...

Patients are turning to unregulated online pharmacies for cheaper versions of GLP-1 drugs. Attorney General William Tong said ...

Measurement of W boson particle mass confirms Standard Model of physics and reignites the search for other particles.

One year of setmelanotide provided reductions in BMI z score for children and body weight for adults with Bardet-Biedl ...

Fury will box the Russian in Tottenham on Saturday, as the ‘Gypsy King’ comes out of retirement for the fifth time ...

The global rise in the prevalence of obesity highlights the need for accessible and effective solutions for obesity ...